Who is sponsoring NCT04857073?

NCT04857073 is sponsored by Icahn School of Medicine at Mount Sinai.

What condition does NCT04857073 study?

NCT04857073 studies Gestational Diabetes.

What drugs are being tested in NCT04857073?

Interventions: Glucose Monitoring.

What is the status of NCT04857073?

NCT04857073 is currently COMPLETED.

Last reviewed 2022-05-03 · How we verify

Daily Versus Every Other Day Glucose Monitoring in Gestational Diabetes Mellitus

NCT04857073 NA COMPLETED

Gestational diabetes mellitus (GDM) occurs secondary to carbohydrate intolerance in pregnancy. Screening of GDM occurs between 24 to 28 weeks gestation by a screening 1-hour 50g glucose challenge test and confirmed with a 100g 3-hour fasting glucose tolerance test. Once patients are diagnosed with GDM, they are instructed to check their fingerstick blood glucose four times daily, every day. There is insufficient evidence to determine the ideal frequency and timing of glucose monitoring in patients diagnosed with GDM and no absolute guidelines put in place by the American College of Obstetricians and Gynecologists (ACOG). The study team aims to confirm non inferiority on the patient population on the effects of daily (4x daily) versus every other day (4x daily) glucose monitoring in all patients diagnosed with GDM.

Details

Lead sponsor	Icahn School of Medicine at Mount Sinai
Phase	NA
Status	COMPLETED
Enrolment	200
Start date	Sat Apr 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Apr 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Gestational Diabetes

Interventions

Glucose Monitoring

Countries

United States